Skip to content
healthcare.dev

Roflumilast

NDC 72205-201, Roflumilast, tablet, from Novadoz Pharmaceuticals LLC.

Product NDC
72205-201
Status
Listed
Labeler
Novadoz Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208256
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72205-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST250 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
72205-201-24722050201242 BLISTER PACK in 1 CARTON (72205-201-24) / 10 TABLET in 1 BLISTER PACK (72205-201-11)
72205-201-307220502013030 TABLET in 1 BOTTLE (72205-201-30)
72205-201-32722050201322 BLISTER PACK in 1 CARTON (72205-201-32) / 14 TABLET in 1 BLISTER PACK (72205-201-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4d25f69c-58b7-4e2a-b835-4d0c76a83c7c
  • NADAC price for package 72205020124

    GET /v1/drugs/nadac/72205020124
  • NADAC price for package 72205020132

    GET /v1/drugs/nadac/72205020132

Use it

Look up 72205-201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72205-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72205-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.